MCID: THY018
MIFTS: 27

Thymus Clear Cell Carcinoma

Categories: Cancer diseases, Endocrine diseases, Immune diseases, Neuronal diseases

Aliases & Classifications for Thymus Clear Cell Carcinoma

MalaCards integrated aliases for Thymus Clear Cell Carcinoma:

Name: Thymus Clear Cell Carcinoma 12 15
Clear Cell Carcinoma of the Thymus 12
Thymic Clear Cell Carcinoma 71

Classifications:



External Ids:

Disease Ontology 12 DOID:8137
NCIt 49 C6462
UMLS 71 C1333069

Summaries for Thymus Clear Cell Carcinoma

MalaCards based summary : Thymus Clear Cell Carcinoma, also known as clear cell carcinoma of the thymus, is related to thymic carcinoma and thymoma, and has symptoms including dyspnea and chest pain. An important gene associated with Thymus Clear Cell Carcinoma is PAX8 (Paired Box 8), and among its related pathways/superpathways is Preimplantation Embryo. Affiliated tissues include thymus, breast and lung, and related phenotypes are no phenotypic analysis and normal

Related Diseases for Thymus Clear Cell Carcinoma

Diseases in the Thymus Large Cell Carcinoma family:

Thymus Small Cell Carcinoma Thymus Clear Cell Carcinoma

Diseases related to Thymus Clear Cell Carcinoma via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 353, show less)
# Related Disease Score Top Affiliating Genes
1 thymic carcinoma 29.1 PAX8 NKX2-1 KRT7 KRT20 KIT CD5
2 thymoma 29.1 TTN NKX2-1 KRT7 KIT CD5 CALB2
3 thymic epithelial tumor 10.5 KIT CD5
4 spindle epithelial tumor with thymus-like differentiation tumor 10.5 KIT CD5
5 primary congenital hypothyroidism 10.5 PAX8 NKX2-1
6 type c thymoma 10.5 KIT CD5
7 trachea adenoid cystic carcinoma 10.5 NKX2-1 KIT
8 thyroid malformation 10.5 PAX8 NKX2-1
9 athyreosis 10.5 PAX8 NKX2-1
10 bladder lymphoma 10.5 KRT20 CD5
11 ectopic thymus 10.4 NKX2-1 CD5
12 rare tumor 10.4 KIT EWSR1
13 nonmucinous bronchioloalveolar adenocarcinoma 10.4 NKX2-1 KRT20
14 rete testis adenoma 10.4 PAX8 CALB2
15 ovarian fibrothecoma 10.4 KIT CALB2
16 myxoid liposarcoma of the ovary 10.4 EWSR1 CALB2
17 liposarcoma of the ovary 10.4 EWSR1 CALB2
18 nephrogenic adenoma 10.4 PAX8 KRT7
19 epithelial malignant thymoma 10.4 TTN CD5
20 spindle cell thymoma 10.4 CD5 CALB2
21 cutaneous ganglioneuroma 10.4 KRT20 KIT
22 extraskeletal ewing sarcoma 10.4 NKX2-1 EWSR1
23 hypothyroidism, congenital, nongoitrous, 2 10.4 PAX8 NKX2-1
24 mixed germ cell-sex cord neoplasm 10.4 KIT CALB2
25 dendritic cell thymoma 10.4 TTN CD5
26 liver leiomyoma 10.4 KIT CALB2
27 benign struma ovarii 10.4 PAX8 NKX2-1
28 vagina leiomyosarcoma 10.4 MLANA KIT
29 malignant anus melanoma 10.3 MLANA KIT
30 ovarian mesodermal adenosarcoma 10.3 PAX8 KRT7
31 peritoneal serous adenocarcinoma 10.3 PTGER4 CALB2
32 thyroid gland anaplastic carcinoma 10.3 PAX8 NKX2-1
33 malignant choroid melanoma 10.3 MLANA CD5
34 small intestine leiomyoma 10.3 MLANA KIT
35 ovarian cystic teratoma 10.3 NKX2-1 MLANA
36 wolffian duct adenoma 10.3 PAX8 KRT7
37 breast hemangiopericytoma 10.3 KRT7 KIT
38 malignant dermis tumor 10.3 MLANA KIT
39 sclerosing hemangioma 10.3 NKX2-1 KRT7
40 renal pelvis adenocarcinoma 10.3 PAX8 KRT7
41 cellular myxoid liposarcoma 10.3 KIT EWSR1
42 cervical adenoid cystic carcinoma 10.3 KRT7 KIT
43 malignant skin fibrous histiocytoma 10.3 MLANA KIT
44 vulvar melanoma 10.3 MLANA KIT
45 urethral diverticulum 10.3 PAX8 KRT7
46 adenoid basal cell carcinoma 10.3 KRT7 KIT
47 biphasic synovial sarcoma 10.3 EWSR1 CALB2
48 solid adenocarcinoma with mucin production 10.3 NKX2-1 KRT7
49 fallopian tube endometrioid adenocarcinoma 10.3 PAX8 CALB2
50 urethral villous adenoma 10.3 KRT7 KRT20
51 pancreatic serous cystadenocarcinoma 10.3 KRT7 KRT20
52 intrahepatic bile duct adenoma 10.3 KRT7 KRT20
53 bile duct adenoma 10.3 KRT7 KRT20
54 vagina sarcoma 10.3 MLANA KIT
55 seminal vesicle adenocarcinoma 10.3 KRT7 KRT20
56 malignant leydig cell tumor 10.3 MLANA CALB2
57 lymphatic system cancer 10.2 TTN KIT CD5
58 ovarian large-cell neuroendocrine carcinoma 10.2 KRT7 KRT20
59 renal adenoma 10.2 PAX8 KRT7
60 ovarian melanoma 10.2 MLANA CALB2
61 atrophic vulva 10.2 KRT7 KRT20
62 aortic malignant tumor 10.2 KRT7 KRT20
63 urinary bladder small cell neuroendocrine carcinoma 10.2 KRT7 KRT20
64 olfactory neuroblastoma 10.2 NKX2-1 EWSR1 CALB2
65 warthin tumor 10.2 KRT7 KIT
66 adult type testicular granulosa cell tumor 10.2 MLANA CALB2
67 testicular granulosa cell tumor 10.2 MLANA CALB2
68 adenofibroma 10.2 KRT7 CALB2
69 bile duct cystadenocarcinoma 10.2 KRT7 KRT20
70 undifferentiated pleomorphic sarcoma 10.2 MLANA KIT
71 colonic lymphangioma 10.2 KRT7 KRT20
72 glomangiomatosis 10.2 MLANA KIT
73 eyelid carcinoma 10.2 KRT7 KRT20
74 esophagus sarcoma 10.2 KRT5 KIT
75 transverse colon cancer 10.2 KRT7 KRT20
76 papillary thymic adenocarcinoma 10.2 PTGER4 CD5 CALB2
77 colon neuroendocrine neoplasm 10.2 NKX2-1 CDX2
78 lymphohistiocytoid mesothelioma 10.2 PTGER4 CD5 CALB2
79 schneiderian carcinoma 10.2 NUTM1 KRT5
80 breast leiomyosarcoma 10.2 KRT7 KIT
81 papillary transitional carcinoma 10.2 KRT7 KRT20
82 ovarian brenner tumor 10.2 KRT7 KRT20
83 mesenchymal cell neoplasm 10.2 MLANA KIT EWSR1
84 lipomatosis, multiple 10.2 MLANA KIT EWSR1
85 perivascular epithelioid cell tumor 10.2 NKX2-1 MLANA KIT
86 epididymal neoplasm 10.2 KRT7 CALB2
87 mediastinum sarcoma 10.2 KRT7 CALB2
88 breast malignant phyllodes tumor 10.2 KRT5 KIT
89 clear cell sarcoma 10.2 MLANA KIT EWSR1
90 pancreatic mucinous cystadenoma 10.2 KRT7 KRT20
91 olfactory nerve neoplasm 10.2 NUTM1 MLANA EWSR1
92 cranial nerve malignant neoplasm 10.2 NUTM1 MLANA EWSR1
93 cranial nerve neoplasm 10.2 NUTM1 MLANA EWSR1
94 muscle cancer 10.1 MLANA KIT EWSR1
95 bladder leiomyoma 10.1 KRT7 KIT EWSR1
96 pulmonary artery leiomyosarcoma 10.1 KRT7 KRT20
97 juvenile type testicular granulosa cell tumor 10.1 MLANA CALB2
98 bladder lateral wall cancer 10.1 KRT7 KRT20
99 clear cell adenocarcinoma 10.1 PAX8 KRT7 KRT20
100 lung leiomyosarcoma 10.1 KRT5 CALB2
101 ovarian serous adenofibroma 10.1 KRT7 CALB2
102 bladder signet ring cell adenocarcinoma 10.1 KRT7 CDX2
103 ovary neuroendocrine neoplasm 10.1 KRT7 CDX2
104 papillary cystadenocarcinoma 10.1 KRT7 KRT20
105 prostate neuroendocrine neoplasm 10.1 KRT7 KRT20
106 anus basaloid carcinoma 10.1 PTGER4 KRT7 KIT
107 nephrogenic adenoma of urinary bladder 10.1 PAX8 KRT7 KRT20
108 pancreatic foamy gland adenocarcinoma 10.1 KRT7 CDX2
109 ovarian serous cystadenofibroma 10.1 KRT7 CALB2
110 adenosquamous colon carcinoma 10.1 KRT7 CDX2
111 nasal cavity adenocarcinoma 10.1 KRT7 CDX2
112 constrictive pericarditis 10.1 TTN CALB2
113 anus adenocarcinoma 10.1 KRT7 CDX2
114 mucinous adenofibroma 10.1 KRT7 CDX2
115 malignant spindle cell melanoma 10.1 MLANA KIT
116 rectum neuroendocrine neoplasm 10.1 KRT7 CDX2
117 mucinous intrahepatic cholangiocarcinoma 10.1 KRT7 CDX2
118 intratubular embryonal carcinoma 10.1 KRT7 KRT20 KIT
119 collecting duct carcinoma 10.1 PAX8 KRT7 KRT20
120 meckel diverticulum 10.1 KIT CDX2
121 anal canal adenocarcinoma 10.1 KRT7 CDX2
122 appendiceal neoplasm 10.1 KRT7 CDX2
123 small cell carcinoma of the bladder 10.1 NKX2-1 KRT7 KRT20
124 testicular fibroma 10.1 KRT5 CALB2
125 biliary papillomatosis 10.1 KRT7 CDX2
126 hidradenoma 10.1 KRT7 KRT5
127 malignant biphasic mesothelioma 10.1 KRT5 CALB2
128 lung acinar adenocarcinoma 10.1 NKX2-1 KRT7 KRT20
129 dysgerminoma 10.1 KRT7 KRT20 KIT
130 cystadenofibroma 10.1 PAX8 KRT7 CALB2
131 pericardial mesothelioma 10.1 KRT5 CALB2
132 dowling-degos disease 1 10.1 KRT5 KIT
133 endosalpingiosis 10.1 PAX8 KRT7 CALB2
134 granular cell tumor 10.0 NKX2-1 MLANA CALB2
135 malignant spiradenoma 10.0 KRT7 KRT5
136 ceruminoma 10.0 KRT7 KRT5
137 sarcomatoid squamous cell skin carcinoma 10.0 MLANA KRT5
138 benign breast adenomyoepithelioma 10.0 KRT7 KRT5
139 breast adenomyoepithelioma 10.0 KRT7 KRT5
140 schwannoma of twelfth cranial nerve 10.0 MLANA KRT7
141 malignant syringoma 10.0 PTGER4 KRT7 KRT20
142 subareolar duct papillomatosis 10.0 KRT7 KRT5
143 lung benign neoplasm 10.0 NKX2-1 KRT7 KRT20
144 sarcomatoid basal cell carcinoma 10.0 PTGER4 KRT5 EWSR1
145 bone leiomyosarcoma 10.0 KRT7 KRT5
146 nipple neoplasm 10.0 KRT7 KRT5
147 squamous papillomatosis 10.0 PTGER4 KRT7 KRT20
148 breast neuroendocrine neoplasm 10.0 KRT20 CDX2
149 tumor of exocrine pancreas 10.0 KRT7 CDX2
150 external ear carcinoma 10.0 KRT7 KRT5
151 ovarian germ cell teratoma 10.0 NKX2-1 KRT7 CALB2
152 vascular cancer 10.0 MLANA KRT7 KIT
153 pelvic lipomatosis 10.0 PAX8 MLANA CDX2
154 gastric squamous cell carcinoma 10.0 KRT7 KRT5
155 thymoma, familial 10.0
156 middle ear adenoma 10.0 KRT7 KRT5
157 pulmonary sclerosing hemangioma 10.0 NKX2-1 KRT7 CALB2
158 breast myoepithelial neoplasm 10.0 KRT7 KRT5
159 nodular malignant melanoma 10.0 MLANA KIT
160 eccrine papillary adenocarcinoma 10.0 KRT7 KRT5
161 hypoglossal nerve disease 10.0 MLANA KRT7
162 necrotizing sialometaplasia 10.0 KRT7 KRT5
163 bile duct mucoepidermoid carcinoma 10.0 KRT7 KRT5
164 breast metaplastic carcinoma 10.0 KRT7 KRT5
165 breast mucinous carcinoma 10.0 KRT7 KRT5
166 ovarian seromucinous carcinoma 10.0 PAX8 KRT7 CDX2
167 middle ear adenocarcinoma 10.0 KRT7 KRT5
168 liver fibroma 10.0 KRT5 KIT CALB2
169 eccrine acrospiroma 10.0 KRT7 KRT5
170 papillary squamous carcinoma 10.0 KRT7 KRT5
171 chordoid glioma 10.0 NKX2-1 KRT7
172 benign mesenchymoma 10.0 KRT7 KRT5
173 eccrine sweat gland neoplasm 10.0 KRT7 KRT5
174 medulloepithelioma 10.0 KRT7 KRT20 CALB2
175 chromophobe renal cell carcinoma 10.0 KRT7 KRT20 KIT
176 eccrine porocarcinoma 10.0 KRT7 KRT5
177 polycystic liver disease 1 with or without kidney cysts 10.0 KRT7 KRT20 CALB2
178 monophasic synovial sarcoma 10.0 KRT7 CALB2
179 middle ear carcinoma 9.9 KRT5 EWSR1 CALB2
180 testicular sex cord-stromal neoplasm 9.9 MLANA CALB2
181 duodenum adenocarcinoma 9.9 KRT7 CDX2
182 neuroendocrine tumor 9.9 NKX2-1 KRT20 CDX2
183 combined thymoma 9.9 PAX8 KRT5 KIT CD5
184 sarcomatoid renal cell carcinoma 9.9 PAX8 KIT GATA3
185 cervical serous adenocarcinoma 9.9 MLANA GATA3
186 malignant epithelial mesothelioma 9.9 PTGER4 KRT5 CALB2
187 thymus basaloid carcinoma 9.9 PAX8 NKX2-1 KRT5 CD5
188 thyroid angiosarcoma 9.9 PAX8 NKX2-1 KRT7 KRT20
189 retroperitoneal sarcoma 9.9 MLANA KIT EWSR1 CALB2
190 gastric signet ring cell adenocarcinoma 9.9 KRT7 KRT20 CDX2
191 signet ring cell adenocarcinoma 9.9 KRT7 KRT20 CDX2
192 clear cell hidradenoma 9.9 PAX8 KRT7 KRT5
193 urinary bladder villous adenoma 9.9 KRT7 KRT20 CDX2
194 cystitis cystica 9.9 KRT7 KRT20 CDX2
195 vulva adenocarcinoma 9.9 KRT7 KRT20 CDX2
196 jejunal adenocarcinoma 9.9 KRT7 KRT20 CDX2
197 krukenberg carcinoma 9.9 KRT7 KRT20 CDX2
198 cell type benign neoplasm 9.9 MLANA KRT7 KIT
199 vaginal tubulovillous adenoma 9.9 KRT7 KRT20 CDX2
200 female urethral cancer 9.9 KRT7 KRT20 CDX2
201 vaginal adenoma 9.9 KRT7 KRT20 CDX2
202 jejunal cancer 9.9 KRT7 KRT20 CDX2
203 vaginal benign neoplasm 9.9 KRT7 KRT20 CDX2
204 appendix adenocarcinoma 9.9 KRT7 KRT20 CDX2
205 apocrine sweat gland neoplasm 9.9 KRT7 KRT5
206 glandular cystitis 9.9 KRT7 KRT20 CDX2
207 ceruminous adenocarcinoma 9.9 KRT7 KRT5 KIT
208 linitis plastica 9.9 KRT7 KRT20 CDX2
209 large cell neuroendocrine carcinoma 9.9 NKX2-1 KRT7 KRT20 KIT
210 appendix disease 9.9 KRT7 KRT20 CDX2
211 neuroendocrine carcinoma 9.9 NKX2-1 KRT7 KRT20 KIT
212 ovarian sex-cord stromal tumor 9.9 MLANA KRT7 CALB2
213 ovarian mucinous adenocarcinoma 9.9 KRT7 KRT20 CDX2
214 appendix cancer 9.9 KRT7 KRT20 CDX2
215 lymphoepithelioma-like thymic carcinoma 9.9 NUTM1 KRT5 KIT CD5
216 gastric diffuse adenocarcinoma 9.9 KRT7 KRT20 CDX2
217 chronic cystitis 9.9 KRT7 KRT20 CDX2
218 cavernous hemangioma 9.9 NKX2-1 KRT7 KRT20 KIT
219 pseudomyxoma peritonei 9.9 KRT7 KRT20 CDX2
220 merkel cell carcinoma 9.9 NKX2-1 KRT7 KRT20 KIT
221 ampulla of vater adenocarcinoma 9.9 KRT7 KRT20 CDX2
222 rectum adenocarcinoma 9.9 KRT7 KRT20 CDX2
223 oncocytoma 9.9 NKX2-1 KRT7 KRT20 KIT
224 tubular adenocarcinoma 9.9 KRT7 KRT20 CDX2
225 rete testis neoplasm 9.9 PAX8 NKX2-1 KRT7 CALB2
226 rete testis adenocarcinoma 9.9 PAX8 NKX2-1 KRT7 CALB2
227 sebaceous adenocarcinoma 9.9 PTGER4 MLANA KRT5
228 small cell cancer of the lung 9.9 NKX2-1 KRT7 KRT20 KIT
229 carcinosarcoma 9.9 PAX8 KRT7 KIT CALB2
230 tonsil cancer 9.9 KRT7 KRT5 KIT
231 sweat gland neoplasm 9.9 KRT7 KRT5 EWSR1
232 oropharynx cancer 9.9 KRT7 KRT5 KIT
233 salivary gland disease 9.9 KRT7 KRT5 KIT
234 lung clear cell carcinoma 9.9 NKX2-1 KRT7 KRT5
235 ampulla of vater cancer 9.9 KRT7 KRT20 CDX2
236 sweat gland disease 9.9 KRT7 KRT5 EWSR1
237 papillary adenoma 9.8 NKX2-1 KRT7 KRT5
238 synovium cancer 9.8 KRT7 KIT EWSR1 CALB2
239 kidney benign neoplasm 9.8 PAX8 MLANA KRT7 KIT
240 ovarian germ cell cancer 9.8 NKX2-1 KRT7 KIT CALB2
241 pleomorphic carcinoma 9.8 NKX2-1 KRT7 KIT CALB2
242 intrahepatic cholangiocarcinoma 9.8 KRT7 KRT20 CDX2
243 malignant peripheral nerve sheath tumor 9.8 MLANA KRT7 KIT
244 angiomyolipoma 9.8 PAX8 MLANA KRT7 KIT
245 metatypical basal cell carcinoma 9.8 PTGER4 KRT7 KRT5
246 colon squamous cell carcinoma 9.8 KRT5 CDX2
247 vulvar disease 9.8 KRT7 KIT
248 papilloma 9.8 KRT7 KRT5 KRT20
249 sarcoma, synovial 9.8 KRT7 KIT EWSR1 CALB2
250 thymus gland disease 9.8 TTN KRT5 KIT CD5
251 anal canal paget's disease 9.8 MLANA KRT7 CDX2
252 anal paget's disease 9.8 MLANA KRT7 CDX2
253 vulvar apocrine adenocarcinoma 9.8 KRT7 KRT5 KRT20
254 ovarian benign neoplasm 9.8 PAX8 KRT7 KRT20 CALB2
255 adenoid squamous cell carcinoma 9.8 KRT7 KRT5 KRT20
256 central epithelioid sarcoma 9.8 KRT7 KRT5 KRT20
257 vulvar proximal-type epithelioid sarcoma 9.8 KRT7 KRT5 KRT20
258 cystadenoma 9.8 KRT7 KRT20 KIT CALB2
259 lymphoepithelioma-like carcinoma 9.8 KRT7 KRT5 KRT20
260 inverted papilloma 9.8 KRT7 KRT5 KRT20
261 epithelial predominant wilms' tumor 9.8 MLANA KRT7 CDX2
262 jejunal neoplasm 9.8 MLANA KRT7 KRT20 KIT
263 primary cutaneous amyloidosis 9.8 TTN KRT7 KRT5
264 bladder benign neoplasm 9.7 PAX8 KRT7 KRT20 KIT EWSR1
265 ovarian wilms' cancer 9.7 PAX8 MLANA KRT7 CALB2
266 ovarian mucinous neoplasm 9.7 PAX8 KRT7 KRT20 CDX2
267 bladder clear cell adenocarcinoma 9.7 PAX8 KRT7 KRT20 CDX2
268 renal cell carcinoma, papillary, 1 9.7 PAX8 KRT7 KIT
269 sensory organ benign neoplasm 9.7 MLANA KRT7 KRT5
270 balloon cell malignant melanoma 9.7 MLANA KRT7 KRT5
271 adenocarcinoma in situ 9.7 PAX8 KRT7 KRT20 CDX2
272 endocervical adenocarcinoma 9.7 PAX8 KRT7 KRT20 CDX2
273 angiosarcoma 9.7 MLANA KRT7 KIT CALB2
274 cardiovascular cancer 9.7 MLANA KRT7 KIT CALB2
275 cystitis 9.7 KRT7 KRT20 KIT CDX2
276 intestinal obstruction 9.7 KRT7 KRT20 KIT CDX2
277 bartholin's gland adenocarcinoma 9.7 PTGER4 KRT7 GATA3
278 sex cord-gonadal stromal tumor 9.7 NKX2-1 MLANA KRT7 CALB2
279 cutaneous adenocystic carcinoma 9.7 NKX2-1 KRT7 KRT5 KIT
280 bronchiolo-alveolar adenocarcinoma 9.7 NKX2-1 KRT7 KRT20 CDX2
281 esophageal adenosquamous carcinoma 9.7 KRT7 KRT5 CDX2
282 adenosquamous carcinoma 9.7 NKX2-1 KRT7 KRT5 KIT
283 endobronchial lipoma 9.7 NUTM1 KRT7 KRT5 EWSR1
284 thyroid gland cancer 9.7 PAX8 NKX2-1 KRT7 KRT20 KIT
285 wilms tumor 1 9.6 PAX8 KRT7 KIT EWSR1 CALB2
286 keratinizing squamous cell carcinoma 9.6 NUTM1 NKX2-1 KRT7 KRT5
287 breast osteosarcoma 9.6 KRT7 KRT5 KRT20 CD5
288 basal cell carcinoma 9.6 KRT7 KRT5 KRT20 KIT
289 blepharocheilodontic syndrome 1 9.6 GATA3 CDX2
290 papillary serous adenocarcinoma 9.6 PAX8 NKX2-1 KRT7 KRT20 CALB2
291 mucinous ovarian cystadenoma 9.6 KRT7 KRT20 CDX2 CALB2
292 papillary carcinoma 9.6 PAX8 NKX2-1 KRT7 KRT20 CALB2
293 eccrine sweat gland cancer 9.6 PTGER4 KRT7 KRT5 KRT20
294 cervical adenocarcinoma 9.6 KRT7 KRT20 CDX2 CALB2
295 heart cancer 9.6 KRT7 KRT5 KIT CALB2
296 cystic basal cell carcinoma 9.6 PTGER4 KRT7 KRT5 KRT20
297 adenoid cystic carcinoma 9.6 KRT7 KRT5 KRT20 KIT
298 cervical mucinous adenocarcinoma 9.6 MLANA KRT7 GATA3
299 adult mesoblastic nephroma 9.5 PAX8 MLANA KRT7 KIT CALB2
300 pericardium cancer 9.5 PTGER4 KRT7 KRT5 CALB2
301 benign peritoneal mesothelioma 9.5 PTGER4 KRT7 KRT5 CALB2
302 laryngeal small cell carcinoma 9.5 NKX2-1 MLANA KRT7 KRT5
303 respiratory system benign neoplasm 9.5 NKX2-1 MLANA KRT7 KRT5
304 adenocarcinoma 9.5 NKX2-1 KRT7 KRT20 KIT CDX2
305 mediastinal cancer 9.5 NKX2-1 KRT7 KRT5 KIT CD5
306 large cell acanthoma 9.5 PTGER4 MLANA KRT7 KRT5
307 small cell carcinoma 9.5 NKX2-1 KRT7 KRT20 KIT CDX2
308 mucinous adenocarcinoma 9.5 NKX2-1 KRT7 KRT20 KIT CDX2
309 mucoepidermoid carcinoma 9.5 PAX8 NKX2-1 KRT7 KRT5 EWSR1
310 colorectal adenocarcinoma 9.5 NKX2-1 KRT7 KRT20 KIT CDX2
311 ureter adenocarcinoma 9.5 NKX2-1 KRT7 KRT5 CDX2
312 borst-jadassohn intraepidermal carcinoma 9.5 MLANA KRT7 KRT5 KRT20
313 paget disease, extramammary 9.5 MLANA KRT7 KRT5 KRT20
314 inverted transitional papilloma 9.5 KRT7 KRT5 GATA3
315 microinvasive cervical squamous cell carcinoma 9.5 KRT7 KRT5 GATA3
316 wolffian duct adenocarcinoma 9.5 PAX8 KRT7 GATA3 CALB2
317 apocrine adenocarcinoma 9.4 KRT7 KRT5 GATA3
318 clear cell basal cell carcinoma 9.4 KRT7 KRT5 KRT20 CDX2
319 thymus adenocarcinoma 9.4 NUTM1 KRT5 KRT20 CDX2 CD5
320 large cell carcinoma 9.4 NKX2-1 KRT7 KRT5 KRT20 KIT
321 ovary adenocarcinoma 9.4 PAX8 KRT7 KRT20 CDX2 CALB2
322 mixed cell type cancer 9.4 PAX8 KRT7 KRT5 KIT CALB2
323 mucinous stomach adenocarcinoma 9.4 KRT7 KRT20 KIT CDX2 CALB2
324 bladder urothelial carcinoma 9.4 KRT7 KRT20 KIT GATA3
325 horseshoe kidney 9.4 NKX2-1 KRT7 KRT20 CDX2 CALB2
326 mucinous bronchioloalveolar adenocarcinoma 9.4 NKX2-1 KRT7 KRT20 CDX2 CALB2
327 benign teratoma 9.4 NKX2-1 KRT7 KRT20 CDX2 CALB2
328 benign mesothelioma 9.4 PTGER4 PAX8 KRT7 KRT5 CALB2
329 renal cell carcinoma, nonpapillary 9.4 PAX8 NKX2-1 KRT7 KRT20 KIT CALB2
330 epididymis adenocarcinoma 9.4 PTGER4 PAX8 KRT7 KRT5 CALB2
331 epididymis cancer 9.4 PTGER4 PAX8 KRT7 KRT5 CALB2
332 peritoneum cancer 9.4 PTGER4 PAX8 KRT7 KRT5 CALB2
333 endocervical carcinoma 9.4 PAX8 KRT7 GATA3 CDX2
334 nephrogenic adenoma of the urethra 9.3 PAX8 KRT7 KRT5 KRT20 CALB2
335 urethral benign neoplasm 9.3 PAX8 KRT7 KRT5 KRT20 CALB2
336 urethra clear cell adenocarcinoma 9.3 PAX8 KRT7 KRT5 KRT20 CALB2
337 uterus leiomyosarcoma 9.3 NKX2-1 MLANA KRT7 KRT5 KIT
338 adenomatoid tumor 9.3 PTGER4 NKX2-1 KRT7 KRT5 CALB2
339 nasal cavity olfactory neuroblastoma 9.3 PAX8 NKX2-1 KRT7 KRT5 CDX2
340 endometrial cancer 9.3 PAX8 NKX2-1 KRT7 KRT20 KIT CALB2
341 mesothelioma, malignant 9.3 NKX2-1 KRT7 KRT5 KRT20 CALB2
342 bladder adenocarcinoma 9.3 KRT7 KRT20 GATA3 CDX2
343 cribriform carcinoma 9.3 KRT7 KRT5 KIT GATA3
344 epithelioid cell synovial sarcoma 9.3 PAX8 KRT7 GATA3 EWSR1 CALB2
345 leber congenital amaurosis 9.2 MLANA KRT7 KRT20 KIT CD5 CALB2
346 thymus cancer 9.2 TTN NKX2-1 KRT7 KRT5 KIT CD5
347 barrett esophagus 9.2 KRT7 KRT20 CDX2
348 sweat gland cancer 9.2 KRT7 KRT5 KRT20 GATA3
349 cystic teratoma 9.2 NKX2-1 KRT7 KRT20 KIT CDX2 CALB2
350 teratoma 9.2 NKX2-1 KRT7 KRT20 KIT CDX2 CALB2
351 nasal cavity cancer 9.1 NUTM1 MLANA KRT7 KRT5 CDX2
352 gastric adenocarcinoma 8.8 TTN KRT7 KRT20 KIT GATA3 CDX2
353 lung cancer susceptibility 3 8.7 NKX2-1 KRT7 KRT5 KRT20 KIT CDX2

Graphical network of the top 20 diseases related to Thymus Clear Cell Carcinoma:



Diseases related to Thymus Clear Cell Carcinoma

Symptoms & Phenotypes for Thymus Clear Cell Carcinoma

UMLS symptoms related to Thymus Clear Cell Carcinoma:


dyspnea, chest pain

MGI Mouse Phenotypes related to Thymus Clear Cell Carcinoma:

45 (showing 2, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 no phenotypic analysis MP:0003012 9.5 CD5 GATA3 KIT KRT5 MLANA NKX2-1
2 normal MP:0002873 9.28 CALB2 CD5 CDX2 GATA3 KIT NKX2-1

Drugs & Therapeutics for Thymus Clear Cell Carcinoma

Search Clinical Trials , NIH Clinical Center for Thymus Clear Cell Carcinoma

Genetic Tests for Thymus Clear Cell Carcinoma

Anatomical Context for Thymus Clear Cell Carcinoma

MalaCards organs/tissues related to Thymus Clear Cell Carcinoma:

40
Thymus, Breast, Lung, Colon, Thyroid, Ovary, Kidney

Publications for Thymus Clear Cell Carcinoma

Articles related to Thymus Clear Cell Carcinoma:

(showing 3, show less)
# Title Authors PMID Year
1
Primary clear cell carcinoma of the thymus and literature comparison of features. 61
29588619 2018
2
Diagnosis of thymic clear cell carcinoma by cytology. 61
24175107 2013
3
Thymic clear cell carcinoma. 61
20155348 2010

Variations for Thymus Clear Cell Carcinoma

Expression for Thymus Clear Cell Carcinoma

Search GEO for disease gene expression data for Thymus Clear Cell Carcinoma.

Pathways for Thymus Clear Cell Carcinoma

Pathways related to Thymus Clear Cell Carcinoma according to GeneCards Suite gene sharing:

(showing 1, show less)
# Super pathways Score Top Affiliating Genes
1 10.58 NKX2-1 GATA3 CDX2

GO Terms for Thymus Clear Cell Carcinoma

Biological processes related to Thymus Clear Cell Carcinoma according to GeneCards Suite gene sharing:

(showing 7, show less)
# Name GO ID Score Top Affiliating Genes
1 cornification GO:0070268 9.5 KRT7 KRT5 KRT20
2 anatomical structure formation involved in morphogenesis GO:0048646 9.4 NKX2-1 GATA3
3 embryonic hemopoiesis GO:0035162 9.37 KIT GATA3
4 mesonephros development GO:0001823 9.26 PAX8 GATA3
5 otic vesicle development GO:0071599 9.16 PAX8 GATA3
6 positive regulation of thyroid hormone generation GO:2000611 8.96 PAX8 GATA3
7 mast cell differentiation GO:0060374 8.62 KIT GATA3

Sources for Thymus Clear Cell Carcinoma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 LOVD
41 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
53 NINDS
54 Novoseek
56 OMIM
57 OMIM via Orphanet
61 PubMed
63 QIAGEN
68 SNOMED-CT via HPO
69 TGDB
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....